Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 8/20 | 0.56 |
| ▸ | HRH1 | P35367 | 12/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 9/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 9/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | HRH2 | P25021 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23908928 | 0.93 | S1PR2 (0.63) | S1PR2HRH1ADRA1AADRA1BKCNH2 | |
| SCHEMBL23966877 | 0.83 | S1PR2 (0.65) | S1PR2HRH1ADRA1AADRA1BKCNH2 | |
| SCHEMBL23909089 | 0.83 | S1PR2 (0.78) | S1PR2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL23908809 | 0.83 | S1PR2 (0.59) | S1PR2 | |
| SCHEMBL23908802 | 0.82 | S1PR2 (0.56) | S1PR2HRH1ADRA1AADRA1BHRH3 | |
| SCHEMBL23908736 | 0.82 | S1PR2 (0.61) | S1PR2 | |
| SCHEMBL23915560 | 0.81 | S1PR2 (0.57) | S1PR2 | |
| SCHEMBL23908829 | 0.81 | S1PR2 (0.57) | S1PR2 | |
| SCHEMBL23908878 | 0.81 | S1PR2 (0.64) | S1PR2 | |
| SCHEMBL23908861 | 0.80 | S1PR2 (0.76) | S1PR2CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3649119-B1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS | GALAPAGOS NV (BE) | 2021-11-03 | — | — | EP | disclosed |